Quasar’s new top-technology production facility

Quasar’s new top-technology production facility in Dongguan to become operational early 2018

We are happy to announce the opening of our new manufacturing facility in Dongguan, China.
The facility is now in the validation phase and will fully operational for mass production during Q1-2018.
The new facility is our newest asset in our effort to deliver higher quality and newer technologies for innovative medical device mass production and process-design services.

The Impact of Quasar’s Crisis Leadership Through Covid-19

As rumors of Covid-19 spread in January 2020, and fear gripped most of China, the management had to face facts and realize that a serious crisis was in the offing. Instead of being paralyzed by fear and uncertainty, Quasar’s leadership headed by Ayal Amitai, CEO, began looking ahead, considering courses of action to get the plant working again.

A Second Medical Device Manufacturing Source As a Risk Mitigation Strategy

Many supply-chain vulnerabilities stem from long lead times and high levels of cyclicity that prevent the maintenance of the right inventory balance. OEM companies must identify and solve supply-chain vulnerabilities and risk exposures by creating effective mitigation and business-continuity plans.